FDA Pharamacogenomic Biomarker Database

2 comments

Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labels may contain information on genomic biomarkers and can describe:

    • Drug exposure and clinical response variability
    • Risk for adverse events
    • Genotype-specific dosing
    • Mechanisms of drug action
    • Polymorphic drug target and disposition genes

This resource table lists FDA-approved drugs with pharmacogenomic information / biomarkers in their labels.

Source:  FDA

2 Comments

  1. Peter Xu, Ph.D., DABT
    Peter Xu, Ph.D., DABT on July 10, 2012 at 9:50 pm

    Please share me some information, and I can donate some ideas and expereince as well.

  2. cdavenport
    cdavenport on July 11, 2012 at 12:34 am

    Peter,

    Thanks for your comment! Other than the information contained in the FDA source article cited above, I do not have further information on this initiative.
    Genomics > Table of Pharmacogenomic Biomarkers in Drug Labels http://bit.ly/FDAgenomicDatabase

    Cynthia